ArticlePloS one2014

Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse.

Jan K Hennigs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.